February 23, 2021Open Access

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study

Key Points

Key points are not available for this paper at this time.

Abstract

Performance of 18F-DCFPyL-PET/CT achieved the study's primary endpoint, demonstrating disease localization in the setting of negative standard imaging and providing clinically meaningful and actionable information. These data further support the utility of 18F-DCFPyL-PET/CT to localize disease in men with recurrent prostate cancer.See related commentary by True and Chen, p. 3512.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Cite This Study

Morris et al. (Tue,) studied this question.

synapsesocial.com/papers/69d73d2b8e958094d1b8a679 https://doi.org/https://doi.org/10.1158/1078-0432.ccr-20-4573

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Discussion

Journals

Clinical Cancer Research

Institutions

Stanford University

University of Michigan

Johns Hopkins University

References and Citations

Add This Paper to Your Research Feed

Any time a new paper drops it will be there.

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study

Key Points

Abstract

Citation Network

Connected Papers

Cite This Study

Also Consider

Discussion

Journals

Institutions

References and Citations

Also Consider